Lucentis
H-1512-107-728
Approved small_molecule completed
Quick answer
Lucentis for Wet Macular Degeneration is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Wet Macular Degeneration
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed